Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pear Therapeutics
MedTech
2024 forecast: Where do digital therapeutics go from here?
FDA green lights have largely failed to translate into profitability for makers of digital therapeutics, many of whom are struggling to stay afloat.
Andrea Park
Dec 22, 2023 9:00am
Pear Therapeutics apps sell for $6M in post-bankruptcy auction
May 19, 2023 2:52pm
Prescription app maker Pear Therapeutics files for bankruptcy
Apr 10, 2023 10:13am
Pear Therapeutics exploring a sale amid hemorrhaging costs
Mar 17, 2023 12:53pm
Biogen's Aduhelm architect departs—Chutes & Ladders
Mar 17, 2023 9:30am
Philips finds new head of recall-laden connected care segment
Mar 14, 2023 10:04am
